Gossamer Bio (GOSS)
(Delayed Data from NSDQ)
$1.98 USD
-0.18 (-8.33%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.98 0.00 (0.00%) 7:12 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Gossamer Bio, Inc. has a market cap of $490.97M, which represents its share price of $2.16 multiplied by its outstanding shares number of 227.30M. As a small-cap company, GOSS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GOSS 1.98 -0.18(-8.33%)
Will GOSS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GOSS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GOSS
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
GOSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
GSK (GSK) Q2 Earnings and Revenues Beat Estimates
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
Other News for GOSS
GOSS: Wedbush Raises Gossamer Bio Price Target to $5 Following Outperform Rating | GOSS Stock News
Gossamer Bio GAAP EPS of -$0.17 in-line, revenue of $11.49M beats by $6.08M
GOSS Achieves Strong Q2 Revenue and Prepares for Commercial Expansion
Gossamer Bio reports Q2 EPS (17c) , consensus (18c)
BlackRock, Inc. Expands Holdings in Gossamer Bio Inc.